Welcome to Pharma Disclosure

This website has been developed as a joint initiative between the European Federation of Pharmaceutical Industries and Associations (EFPIA) and VitalTransformation.com to highlight the industry’s new rules on disclosing financial relationships with doctors and healthcare organisations, follow progress in the implementation and to monitor compliance in the 33 countries involved in the initiative  …Read more

Events

  • WEBINAR: The EFPIA Code  “Moving The Industry/Health Care Professional Partnership Forward”

WEBINAR: The EFPIA Code “Moving The Industry/Health Care Professional Partnership Forward”

September 16th, 12:30 - 14:00 CET (11:30 - 13:00 UK)

In preparation for the implementation of The EFPIA Code outlining the disclosure of transfers of value to healthcare professionals, this webinar is an opportunity to discuss the relationship between practitioners and industry, and how improved transparency will ultimately lead to greater trust and improved patient outcomes.

Lastest News

  • Collaboration is at the Heart of Personalised Medicine – and This Must be Underpinned by Trust

Collaboration is at the Heart of Personalised Medicine – and This Must be Underpinned by Trust

  • October 21st, 2014

by Carin Smand

Translating the basic science of genomics into medical innovation in the form of personalised medicines requires a high level of interchange between healthcare professionals and the industry. It is critical that these relationships are based on trust and a mutual understanding, says Carin Smand, Managing Director of the European Haematology Association.
  • Cloudy Outlook as Sun Rises on Open Payments

Cloudy Outlook as Sun Rises on Open Payments

  • October 21st, 2014
The US database disclosing transfers of value from pharma and medical technology companies to doctors went live at the end of September with details of 4.4 million transactions. But there are complaints it has not delivered transparency
  • Germany reports progress in implementing financial disclosure rules

Germany reports progress in implementing financial disclosure rules

  • September 19th, 2014

by Holger Diener

Over the past ten years pharmaceutical companies in Germany have proactively responded to the general trend towards greater transparency that has swept across public and corporate life. This puts the industry on the front foot in implementing the new financial disclosure code, says Dr Holger Diener, Managing Director, Association of Voluntary Self-Regulation for the Pharmaceutical Industry